AKBA · Categories · Form 3

AKBA - SEC Form 3 initial insider statements

Akebia Therapeutics Inc. (AKBA) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for AKBA

• 67d
  SEC Form 3 filed by new insider Vickers Philip J.

  3 - Akebia Therapeutics, Inc. (0001517022) (Issuer)
• 126d
  New insider Rucci Carolyn M. claimed ownership of 468,150 shares (SEC Form 3)

  3 - Akebia Therapeutics, Inc. (0001517022) (Issuer)
• 713d
  SEC Form 3 filed by new insider Ostrowski Erik

  3 - Akebia Therapeutics, Inc. (0001517022) (Issuer)
• 873d
  SEC Form 3 filed by new insider Grund Nicholas

  3 - Akebia Therapeutics, Inc. (0001517022) (Issuer)
• 873d
  SEC Form 3 filed by new insider Malabre Richard C

  3 - Akebia Therapeutics, Inc. (0001517022) (Issuer)
• 1057d
  SEC Form 3 filed by new insider Snow Ellen

  3 - Akebia Therapeutics, Inc. (0001517022) (Issuer)
• 1679d
  SEC Form 3 filed by new insider Frieson Ron

  3 - Akebia Therapeutics, Inc. (0001517022) (Issuer)
• 1937d
  SEC Form 3 filed by M Leanne Zumwalt

  3 - Akebia Therapeutics, Inc. (0001517022) (Issuer)
• 1958d
  SEC Form 3: Violetta Cotreau claimed ownership of 12,900 units of Common Stock

  3 - Akebia Therapeutics, Inc. (0001517022) (Issuer)

Other AKBA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends